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Abstract:
Objectives: This work aimed to study respiratory disorders and pulmonary function 
tests among workers in a tobacco factory along with measurements of levels of 
serum IgE, and urinary cotinine and studying dust level inside the factory. Subjects 
& methods: The study was carried out on 79 randomly selected tobacco processing 
workers in a tobacco manufacturing factory in Menoufia Governorate and 80 
voluntarily participating controls. Both groups matched for age, sex, residence, income 
and educational level and were subjected to a structured chest symptoms questionnaire, 
clinical chest examination, spirometric measurements and measurements of total 
serum IgE (IU/ml) and urinary cotinine (ng/ml) by Enzyme Immuno Assay (EIA). 
Environmental total and respirable dust was measured inside the factory. Results: 
Tobacco workers reported significantly higher respiratory symptoms and signs (cough, 
expectoration and wheezes), (P<0.05) as compared with controls and had lower mean 
values of predicted spirometric measurements (FVC, FEV1 and FEV1/FVC), P<0.001. 
Values of serum IgE level (IU/ml) and urinary cotinine (ng/ml) were significantly 
higher among tobacco workers (75.06 + 43.69 and 1422.73 + 1265.59) than controls 
(57.43 + 38.55 and 84.33 + 82.89, respectively), P < 0.05. Smoker and non-smoker 
tobacco-exposed workers had statistically significantly lower mean percentage values 
of predicted of FVC, FEV1 and FEV1/FVC as compared with smoker and non-smoker 
controls, (P <0.05). In addition, urinary cotinine and serum Ig E were significantly 
higher among smoker and non-smoker exposed workers as compared with exposed and 
non-smoker controls. A negative weak and significant correlation between spirometric 
measurements and levels of serum Ig E is noted among tobacco workers. Conclusion: 
The respiratory impairments noted among tobacco processing workers might be due to 
their exposure to the work environment and sensitization to tobacco dust.
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Introduction:
Respiratory impairment among 
workers was reported to be caused by 
exposure to varieties of dusts in small and 
large scale industries generated during 
their production processes; (Czeslawa 
et al., 1998).The nature of respiratory 
diseases caused by occupational dust is 
influenced by the type of dust and duration 
of exposure, (Mengesha and Bekele, 
1998). Occupational diseases are caused 
by a pathologic response of the patients 
to their working environment, (Imbus, 
1994). Health disorders among tobacco 
workers have been reported as early as the 
beginning of the 18th century. Ramazzini 
in 1713 wrote about diseases of tobacco 
workers especially respiratory ones. 
The health effects that tobacco workers 
complained of were associated with their 
workplace and in particular with the ill 
ventilated, damp conditions and with dust 
resulting from grinding of tobacco leave in 
the mill, (Jadranka et al., 2003). Tobacco 
dust contains various immunologically 
active as well as toxic substances, however 
the relationship between allergic reactivity, 
lung function with chronic exposure to 
tobacco dust remains unclear,(Quanjer et 
al., 1993). 
In occupational respiratory diseases, 
spirometry is one of the most important 
diagnostic tools. It is the most widely 
used instrument to evaluate the pulmonary 
function status of a subject and can measure 
and judge the restriction or obstruction of 
lung function if any , (Ruppel, 1997). 
Zaghloul and El- Samra (1974) stated 
that the urinary nicotine levels were 
significantly increased after the work shift 
in tobacco workers. Zuskin et al., (2004), 
found that cotinine (product of nicotine 
metabolism, which is used as an indicator 
that nicotine has been inhaled or otherwise 
introduced in the body) could be detected 
in urine two to four days after tobacco 
exposure.
Aim of the work:
This work aims to:
1- Study respiratory disorders among 
workers in a tobacco factory.
2- Measure serum IgE, and urinary cotinine 
levels in the studied groups.
3- Study dust level inside the factory.
Subjects and Methods:
This study was carried out from April 
1st 2006 through December 2007 in a 
tobacco processing factory which produces 
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“Meaasel” (tobacco for handmade cigarettes 
and for chewing and snuffing) in Shebin El 
Kom city – Menoufia governorate. 
Tobacco processing in the factory 
includes opening of tobacco leave bales, 
then cutting and grinding leaves by machine 
to different sizes according to the required 
end product and finally packing. 
The only ventilation available is natural 
one through windows close to the roof. 
Working hours are from 8.00 am to 5.00 
pm. Workers are exposed to tobacco mainly 
through inhalation and skin contact and 
none of the workers use skin or respiratory 
protection. 
Subjects:
The workforce of the tobacco factory 
consists of 98 workers of whom 79 agreed 
to participate in the study (participation 
rate 81%); we also examined 80 control 
individuals who did not previously work 
in tobacco processing or smoke cigarettes 
and/or Shisha. Both exposed workers 
and controls were matched for age, 
sex, residence, income and educational 
level. Both groups agreed to participate 
voluntarily after explaining to them the 
objectives, tools and health risks and 
benefits and we also get approval from 
the factory administration and the Ethical 
Committee at Faculty of Medicine, 
Menoufia University.
 Methods:
Each participant was subjected to the 
following: 
1-Personal interview and filling an 
already prepared questionnaire, which 
included an inquiry about personal data, 
occupational history and medical history 
of respiratory and skin symptoms.
2- Clinical examination 
General examination; weight, height, 
blood pressure, pulse, temperature in 
addition to local chest and skin examination.
3- Laboratory investigations: 
 A- Spirometry: 
All parameters were measured using 
portable spirometer Spirolab II (Quest 
medical spirometry and equipment and 
supplies, MA, USA). The test was done in 
the sitting position and the subject was told, 
in simple words, the principles of the test. 
Measurements obtained were expressed as 
percentage of predicted for standing height, 
weight, age and sex of tested participants 
and include; VC, FVC, FEV1, FEV1/FVC 
and FEF 25-75.
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B- Blood measurements of:
1- Total serum IgE level:
By using the Immunoglobulin-E 
(IgE) Enzyme Immunoassay. This is 
used for quantitative determination of 
Immunoglobulin E (IgE) concentration in 
human serum. Levels were expressed in 
IU/ml.
2- Urinary cotinine level:
By Enzyme Immunoassay (EIA) using 
Cotinine Urine Kit (M155u1) manufactured 
by COZART Bioscience Ltd, Oxfordshire, 
UK. Levels were expressed in ng/ ml.
4- Environmental studies:
Total and respirable dust was measured 
inside different departments of the Factory 
by the Hexhelt dust sampler through 
collection of three samples from each 
department and taking their average as 
the end result. Dust concentrations were 
expressed in mg / m3.
Statistical analysis:
The collected data were tabulated 
and analyzed by SPSS statistical package 
version 11 on IBM compatible computer. 
Quantitative data were expressed as mean 
and standard deviation ( X +SD) and 
analyzed by applying student t-test for 
comparison of two groups of normally 
distributed variables and Mann Whitney 
U- test for non-normally distributed ones. 
Qualitative data were expressed as number 
and percentage and analyzed by applying 
Chi-square test. Spearman rank correlation 
(rs) was used to detect association between 
non-parametric quantitative variables. 
Level of significance was set as P < 
0.05.
Results:
 The environmental dust studies at 
the  different departments of the tobacco 
factory revealed that the averages of total 
and respirable dust concentrations (mg/m3) 
were highest in the bale opening department 
(42.50 and 13.10 respectively) followed by 
the cutting and grinding department (21.40 
and 6.40, respectively) and were least in 
the  packing department (10.20 and 1.98, 
respectively).
Exposed workers and control 
subjects were matched regarding age, 
anthropometric measurements, sex, 
marital status, residence, income and 
education level and smoking habit (P > 
0.05). The mean age of exposed workers 
was 25.34 ± 8.30 compared with 24.30 ± 
9.11 years for control subjects. The height 
(cm) and weight (kg) of exposed workers 
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and controls was nearly similar (166.81 
±10.31 and 166.39±11.45, respectively) 
and (69.35±17.89 and 67.53±11.82, 
respectively). Exposed workers and 
controls were also matched regarding their 
body mass index (BMI), (24.60±4.50 and 
24.46±3.56, respectively). Forty eight 
workers (60.75%) were males and 31 
(39.25%) were females compared with 55 
(66.25%) male controls and 25 (33.75%) 
female controls, p >0.05.  Forty percent of 
the tobacco workers were smokers, while 
53.75% of the controls were smokers, p 
>0.05.
Chest manifestations among tobacco 
processing workers included cough, 
wheeze, expectoration and chest tightness, 
and were significantly more prevalent 
(46.80%, 40.50%, 40.50% and 22.78%) 
compared with controls (22.50%, 13.75%, 
17.50% and 00.00%, respectively) (P < 
0.05, table 1).
Mean values of spirometric 
measurements expressed as percentage 
of predicted values (FVC%, FEV1% 
and FEV1/FVC% )  were significantly 
lower in exposed tobacco workers (74.23 
+ 17.19, 78.30 + 18.07 and 100.85 + 
8.75,respectively) than controls (87.80 + 
15.91, 91.15 + 16.94 and 105.54 + 11.08, 
respectively ) ,(P < 0.001, table 2).
On studying the levels of biological 
markers, (serum IgE and urinary cotinine), 
there were statistically significantly 
increased values of serum IgE level (IU/
ml) and urinary cotinine (ng/ml) among 
exposed (75.06 + 43.69 and 1422.73 + 
1265.59, respectively) than controls (57.43 
+ 38.55 and 84.33 + 82.89, respectively), 
(P < 0.05, table 3).
Exposed smoking workers had 
statistically significantly lower mean 
percent of predicted values of spirometric 
measurements [FEV1% (72.57 + 16.84), 
FVC% (75.60 + 16.77) and FEV1/FVC % 
(101.13 + 7.91)], compared with smoking 
controls, [FEV1% (83.31 + 17.80), FVC% 
(84.41 + 16.51) and FEV1/FVC %  (105.57 
+ 9.27 )] (P < 0.05, table 4).
Nonsmoking tobacco exposed  workers 
had statistically significantly lower 
mean values  expressed as percentage 
of predicated FVC, FEV1 and  FEV1/
FVC (78.76 + 18.78, 84.31 + 20.63 and 
100.55 + 9.64, respectively) as compared 
with nonsmoking controls (90.91 + 
12.29, 96.14+ 14.44 and 107.66 + 12.51, 
respectively), (P <0.05, table 4). 
Levels of serum IgE and urinary cotinine 
were statistically significantly higher 
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among exposed smoking workers (76.64 + 
45.36 and 1585.79 + 1333.65, respectively) 
than among control smokers (68.50 + 
46.36 and 136.14 + 80.86, respectively). 
Moreover, exposed non-smokers had 
statistically significantly higher values than 
controls non-smokers of serum IgE (IU/
ml) (71.69+47.54 vs.47.54+27.74) and 
urinary cotinine (ng/ml) (1283.90+20.96 
vs. 20.96+15.78) (P < 0.05, table 5).
The values of serum IgE were 
weakly but significantly correlated with 
FVC, FEV1, FVC/FEV1 and FEF25-75 
measurements (rs= -0.258, -0.238,-0.233, 
-0.237 respectively, in exposed workers 
(P<0.05). On the other hand, urinary 
cotinine (ng/ml) had very weak and non-
significant correlation with the percentage 
of predicted measured spirometric tests, 
(rs = 0.159, 0.085, 0.169, 0.174 and 0.144 
respectively).
Table (1):  Distribution of respiratory manifestations among studied groups
 Chest manifestations
Studied groups
χ2 PExposed Workersn=79
Controls
n=80
No                % No                  %
 Cough
Yes
No
37             46.80
42              53.20
18            22.50
62            77.50
10.40 < 0.01*
Wheezes
Yes
No
32              40.50
47              59.50
11            13.75
69             86.25
14.83 < 0.001*
Expectoration
Yes
No
32              40.50
47              59.50
14            17.50
66             82.50
10.23 < 0.01*
Crepitation
Yes
No
15              18.98
64               81.02
7               8.75
73             91.25 3.49 > 0.05
Chest tightness
Yes
No
18               22.78
61               77.22
0               00.00
80           100.00
20.56 < 0.001*
* = Statistically significant
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Table (2): Mean values of spirometric measurements expressed as percentage of predicted 
among the studied groups
Spirometric measurements
(Percent of predicted)
Group
t-test P
Exposed Workers
n=79
Controls
n=80
    ±     SD     ±     SD
FVC% 74.23 ± 17.19 87.80  ± 15.91 5.16 < 0.001*
FEV1% 78.30 ± 18.07
91.15  ± 16.90
4.62
< 0.001*
FEV1/FVC% 100.85 ± 8.75
105.54  ± 11.08 3.59 < 0.001*
FEF 25-75% 111.76 ± 39.61 121.57 ± 34.24 1.67 > 0.05
X X
Table (3): Comparison of mean ± SD of serum IgE and urinary cotinine among exposed 
and control participants
Studied
variables
Group
Mann-
 Whitney
U-test
PExposed Workersn=79
Controls
n=80
   ±    SD median   ±   SD median
Serum IgE
( IU/ml) 75.06±43.69     46.76 57.43± 38.55 31.67 2.77 < 0.05*
 Urinary
Cotinine (ng/ml) 1422.7±1265.6 1234.12 84.33± 82.89 56.34 10.50 < 0.001*
X X
* = Statistically significant
* = Statistically significant
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Table (4): Studied spirometric measurements (% of predicted) of exposed tobacco workers 
and controls according to smoking habit
parameter  Smokinghabit
 Tobacco
workers
 Smoking
habit controls t-test P
FVC
(%)
 Smoker
n=   32
 Non-smoker
n=47
72.57±16.84
78.76±18.78
 Smoker
 n= 43
 Non-smoker
n=37
83.31±17.80
90.91±12.29
2.64
3.40
<0.05*
<0.05*
FEV1
(%)
 Smoker
n=   32
 Non-smoker
n=43
75.60±16.77
84.31±20.63
 Smoker
 n= 43
 Non-smoker
n=37
84.41±16.51
96.14±14.44
2.27
2.96
<0.05*
<0.05*
FVC/FEV1
(%)
 Smoker
n=   32
 Non-smoker
n=43
101.13±7.91
100.55±9.64
 Smoker
 n= 43
 Non-smoker
n=37
105.57±9.27
107.66±12.51
2.18
2.94
<0.05*
<0.05*
FEF 25-75
(%)
 Smoker
n=   32
 Non-smoker
n=43
101.52±36.56
126.76±39.65
 Smoker
 n= 43
 Non-smoker
n=37
105.61±31.30
134.87±30.60
0.52
1.03
>0.05
>0.05
Table (5): serum Ig E (IU/ml) and urinary cotinine (ng/ml) levels of exposed tobacco 
workers  and controls according to smoking habit
parameter  Smokinghabit
 Tobacco
workers
 Smoking
habit controls
Mann-
 Whitney
U-test
P
Serum IgE
( IU/ml)
 Smoker
n=   32
 Non-smoker
n=43
76.64±45.36
71.69±22.36
 Smoker
 n= 43
 Non-smoker
n=37
68.50±46.36
47.54±27.74
2.36
2.13
<0.05*
<0.05*
 Urinary
 Cotinine
(ng/ml)
 Smoker
n=   32
 Non-smoker
n=43
1585.8±1333.6
1283.9±1231.2
 Smoker
 n= 43
 Non-smoker
n=37
136.14±80.86
20.96±15.78
6.66
7.83
<0.001*
<0.001*
* = Statistically significant
* = Statistically significant
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Discussion:
Tobacco dust contains various 
immunologically active as well as toxic 
substances. It has been established that 
occupational exposure to the dust of tobacco 
leaves is associated with significant increase 
in the occurrence of mild obstructive 
ventilatory disturbances, (Ignacak et al., 
2002). Tobacco dust mainly contains 
nitrosamines, which are readily absorbed 
by the body tissues like skin, respiratory 
epithelium and mucus membrane of mouth, 
nose and intestines. Exposure to tobacco 
dust is known to affect the respiratory tract 
in humans, (Umadevi et al., 2003).
The environmental study at the tobacco 
processing factory revealed that workers 
were exposed to high levels of respirable 
and total dust. These levels were higher 
than those reported by (Uitti et al., 1998) 
and (Chloros et al., 2004). There is no 
specified permissible exposure level of 
respirable tobacco dust; however, Popovic 
et al., 1992 recommended a permissible 
level as 0.5 mg/m3.  
Both exposed workers and controls 
were matched regarding age, sex, 
residence, and income and educational 
level, and they showed no statistically 
significant difference in anthropometric 
measurements, and smoking habit.
Tobacco processing workers had 
significantly more prevalent chest 
symptoms and signs compared with 
controls; (table 1).This could be due 
to exposure to high tobacco dust 
concentrations due to bad ventilation in the 
work place. Several investigators, [Lander 
and Gravesend (1988) and Osim et al., 
(1998)] reported an increased prevalence 
of respiratory findings including asthma 
and chronic obstructive bronchitis among 
tobacco workers when compared with 
control subjects. Jadranka et al., (2003), 
revealed that the most frequent chest 
manifestations among tobacco workers 
are cough (29.9%) and wheeze (16.50%). 
Chattopadhyay et al., (2006), found similar 
results of increased respiratory symptoms 
among exposed tobacco workers compared 
to control subjects. 
Spirometric measurements among 
tobacco workers were significantly lower 
than those of controls regarding percentage 
of predicted values of FVC, FEV1 and FVC/
FEV1.These results are in concordance 
with that reported by Jadranka et al., 
2003 ,who found that the mean measured 
values of ventilatory capacity tests (FEV1, 
FEF50, FEF25) in tobacco workers were 
significantly decreased in relation to their 
predicted values. Also, Kjaergaard et al., 
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1989 described significantly decreased 
FVC and FEV1 values in tobacco workers 
compared to their referents. In addition, 
Yanev, 1987 and Popovic et al., 1992 
reported lower values of spirometric 
measurements mostly of the obstructive 
type in tobacco workers compared to their 
control referents.
Smoker and non-smoker tobacco 
workers had significantly lower values 
of FVC%, FEV1% and FEV1/FVC% as 
compared with smoker and non-smokers 
controls. This could be attributed to the 
effect of occupational exposure to tobacco 
dust on the respiratory system regardless of 
their smoking habit status. 
Levels of serum IgE and urinary 
cotinine were significantly increased 
among tobacco processing workers than 
among controls, (table 3). Uitti et al., 1998, 
in their study of cigar factory workers 
revealed that titres of Ig E antibodies among 
tobacco workers were higher than those 
among referents. As regards cotinine, our 
results agree with those of Bahattin et al., 
1999, who reported that tobacco workers 
had significantly higher urinary cotinine 
/creatinine ratios than controls. Also, 
Ghosh et al., 1985 found in their study on 
workers handling tobacco leaves that the 
rate of urinary excretion of nicotine and its 
metabolite cotinine is increased in most of 
the exposed persons.
Serum IgE and urinary cotinine were 
significantly increased among smokers and 
non-smokers tobacco workers than among 
controls. Bahattin et al., 1999, reported 
that non-smoking tobacco workers had 
significantly higher urinary cotinine/
creatinine ratio than non-smoking controls.
 Cotinine is made only from nicotine 
that enters the body with cigarette smoke, 
it can be used as an indicator of a person’s 
exposure to smoke and its measurements 
can provide evidence that tobacco entered 
the body (Caraballo et al., 1998). People 
who do not smoke or who are not exposed 
to other peoples’ smoke should not have 
measurable cotinine. People who do smoke 
will have a cotinine level of 10 or higher in 
their blood, and a typical smoker has levels 
of 150 to 450 units, (Foundation for Blood 
Research, 2010). The values measured in 
the studied workers were far higher than 
450 ng/ml, in both smoking and smoking 
workers.     
Tobacco exposed workers showed a 
negative weak but significant correlation 
between serum IgE hand and spirometric 
measurements. This association may 
imply an immunogenic theory on the 
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pathogenesis of respiratory impairment 
among tobacco processing workers. Becker 
et al., 1986, stated that tobacco leaf itself 
consists of proteins that can act as allergens 
and produce immunoglobulin E (IgE) 
antibodies in exposed workers.  
Conclusion:
 Dust levels inside the tobacco factory 
were high as compared with the suggested 
permissible level. Exposure to tobacco dust 
may be the cause of increased prevalence 
of chest manifestations (cough, wheezes 
and expectoration), high serum IgE and 
urinary cotinine levels. Change in the 
mean values of different spirometric 
measurements among exposed workers 
compared with control group is possibly 
due to sensitization to tobacco dust.     
Recommendations:
Respiratory disorders can be prevented 
or reduced by use of appropriate respiratory 
and hand protection , proper ventilation of 
work environment and the use of engineering 
control measures along with application of 
pre-employment and periodic medication 
examination with special emphasis on the 
respiratory system and measurement of 
serum IgE and urinary cotinine as markers 
of exposure.
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